Real-world cardiovascular risks with novel hormonal therapies in advanced prostate cancer
Real-world cardiovascular risks with novel hormonal therapies in advanced prostate cancer
Lutetium-177 PSMA-617 improves progression-free survival without worsening QoL in mHSPC
Patients with non-metastatic HSPC prefer ARPI-based therapy over androgen deprivation alone
Rethinking access to cancer care across African health systems
Rebalancing technology and compassion in cancer care
The role of nurses in strengthening cancer care in Africa
Integrating women’s perspectives into global cancer care and policy
Post-treatment exercise programme improves survival for stage II/III colon cancer
Enhancing cancer care in Africa: Patient perspectives and quality improvement
Key insights on breast cancer in Cape Verde
Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC
ESMO 2025: Highlights and analysis